🔎 Trials Near Me

ホーム › バーキットリンパ腫 › ペンシルベニア › Philadelphia

Philadelphia、PAにおけるバーキットリンパ腫の臨床試験

Philadelphiaとその周辺地域(約30マイル以内)の拠点で、バーキットリンパ腫に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

被験者募集中第3相
  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
1歳以上 · 全性別 · 2026/10/05更新 · NCT07223021

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

被験者募集中第1相
  • Children's Hospital of Philadelphia, Philadelphia
0歳〜18歳 · 全性別 · 2026/10/05更新 · NCT06173518

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

被験者募集中第2相
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25マイル先
366 Days – 46 Years · 全性別 · 2026/10/02更新 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

被験者募集中第3相
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
18歳〜39歳 · 全性別 · 2026/10/02更新 · NCT03150693

Blinatumomab Consolidation in Real World

被験者募集中観察研究健康なボランティア歓迎
  • University of Pennsylvania, Philadelphia
18歳以上 · 全性別 · 2026/10/01更新 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

被験者募集中観察研究
  • Children's Hospital of Philadelphia, Philadelphia
0歳〜38歳 · 全性別 · 2026/10/01更新 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

被験者募集中第2相
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25マイル先
365 Days · 全性別 · 2026/09/25更新 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

被験者募集中第1/2相
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · 全性別 · 2026/09/17更新 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

被験者募集中第2相
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25マイル先
1歳〜30歳 · 全性別 · 2026/09/01更新 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

被験者募集中第3相
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25マイル先
365 Days – 25 Years · 全性別 · 2026/08/25更新 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

被験者募集中第2相
  • Children's Hospital of Philadelphia, Philadelphia
7歳〜25歳 · 全性別 · 2026/08/19更新 · NCT05082519

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

被験者募集中
  • Children's Hospital of Philadelphia, Philadelphia
25歳以下 · 全性別 · 2026/07/08更新 · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

被験者募集中第1/2相
  • Children's Hospital of Philadelphia, Philadelphia
0歳〜29歳 · 全性別 · 2026/05/26更新 · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

被験者募集中第1/2相
  • Children's Hospital of Philadelphia, Philadelphia
29歳以下 · 全性別 · 2026/03/27更新 · NCT05674175

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

被験者募集中第1/2相
  • Children's Hospital of Philadelphia, Philadelphia
15歳〜50歳 · 全性別 · 2025/09/09更新 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

被験者募集中第2相
  • Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · 25マイル先
1歳〜25歳 · 全性別 · 2025/05/04更新 · NCT03509961

他の都市におけるバーキットリンパ腫の試験

Philadelphiaにおける他の研究

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。